JASON ARTHINGTON: Open Payments
NPI 1073825519 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 23 payments from 12 companies in 2025. Trend: 2023 $482 · 2024 $589 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Lilly USA, LLC | 3 | $44 |
| ABBVIE INC. | 2 | $39 |
| Novo Nordisk Inc | 2 | $33 |
| Abbott Laboratories | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, FREESTYLE LIBRE 3, MOUNJARO, REXULTI, AVYCAZ, CAPLYTA, SPRAVATO.
Industry payments across OK — which companies pay providers there.
